Vertellus Holdings LLC entered into a definitive agreement to acquire Potassium Chloride (KCl) and Vaccine Adjuvants Businesses from Chemtrade Logistics Income Fund (TSX:CHE.UN) for approximately $160 million on September 30, 2021. Chemtrade will use the net proceeds of the sale to reduce bank debt. Based upon the midpoint of guidance for 2021 provided by Chemtrade in August 2021, and after making a pro-forma adjustment for the loss of a full year?s EBITDA of the disposed businesses, this repayment will reduce Chemtrade?s senior Debt: EBITDA ratio by approximately 0.7 times. These businesses generated approximately $14.3 million of EBITDA during the twelve months ended June 30, 2021.The transaction is subject to regulatory approval and customary closing conditions and is expected to close during the fourth quarter of 2021. BMO Capital Markets is acting as financial advisor to Chemtrade in connection with the transaction.